97465-70-8 Usage
Uses
Used in Pharmaceutical Industry:
(6R)-6,7,8,9-Tetrahydro-6β,7β-dihydroxy-1,6-dimethylphenanthro[1,2-b]furan-10,11-dione is used as a pharmaceutical agent for its antifungal and antibacterial properties. Its ability to inhibit the growth of various fungi and bacteria makes it a potential candidate for the development of new antimicrobial drugs to combat drug-resistant infections.
Used in Anti-inflammatory Applications:
(6R)-6,7,8,9-Tetrahydro-6β,7β-dihydroxy-1,6-dimethylphenanthro[1,2-b]furan-10,11-dione is used as an anti-inflammatory agent due to its ability to reduce inflammation in various conditions. Its anti-inflammatory properties can be harnessed to develop new treatments for inflammatory diseases, such as arthritis, asthma, and inflammatory bowel diseases.
Used in Anticancer Applications:
(6R)-6,7,8,9-Tetrahydro-6β,7β-dihydroxy-1,6-dimethylphenanthro[1,2-b]furan-10,11-dione is used as an anticancer agent for its potential to inhibit the growth and proliferation of cancer cells. Its anticancer activities have been demonstrated in various studies, making it a promising candidate for the development of new cancer therapies.
Used in Drug Delivery Systems:
To enhance the bioavailability and therapeutic outcomes of (6R)-6,7,8,9-Tetrahydro-6β,7β-dihydroxy-1,6-dimethylphenanthro[1,2-b]furan-10,11-dione, novel drug delivery systems can be developed. These systems, such as organic and metallic nanoparticles, can improve the compound's delivery to target tissues, increasing its efficacy and reducing potential side effects.
Check Digit Verification of cas no
The CAS Registry Mumber 97465-70-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,7,4,6 and 5 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 97465-70:
(7*9)+(6*7)+(5*4)+(4*6)+(3*5)+(2*7)+(1*0)=178
178 % 10 = 8
So 97465-70-8 is a valid CAS Registry Number.
97465-70-8Relevant academic research and scientific papers
Total synthesis of (±)-tanshinol B, tanshinone I, and (±)-tanshindiol B and C
Wang, Fan,Yang, Hong,Yu, Shujuan,Xue, Yu,Fan, Zhoulong,Liang, Gaolin,Geng, Meiyu,Zhang, Ao,Ding, Chunyong
, p. 3376 - 3381 (2018/05/23)
A concise and efficient approach was established for the divergent total synthesis of (±)-tanshindiol B and C and tanshinone I from a ubiquitous ene intermediate in 1-2 steps. This critical intermediate was derived from (±)-tanshinol B, which was synthesized in 50% overall yield over 3 steps using an ultrasound-promoted cycloaddition as a key step. Compared to a previously reported strategy, our approach is more step-economic, thus greatly improving the synthetic efficiency. The bioactivity evaluation indicates that the diol stereochemistry of the tanshidiols has an impact on the EZH2 inhibitory activity.
